LEADER 05439nam 2200685Ia 450 001 9910141246603321 005 20200520144314.0 010 $a1-283-28271-2 010 $a9786613282712 010 $a1-118-10176-6 010 $a1-118-10177-4 010 $a1-118-10175-8 035 $a(CKB)2670000000122697 035 $a(EBL)697475 035 $a(OCoLC)761321510 035 $a(SSID)ssj0000554778 035 $a(PQKBManifestationID)11358089 035 $a(PQKBTitleCode)TC0000554778 035 $a(PQKBWorkID)10517167 035 $a(PQKB)10986776 035 $a(MiAaPQ)EBC697475 035 $a(Au-PeEL)EBL697475 035 $a(CaPaEBR)ebr10577648 035 $a(CaONFJC)MIL328271 035 $a(PPN)204444748 035 $a(EXLCZ)992670000000122697 100 $a20110307d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aFundamental medical mycology$b[electronic resource] /$fErrol Reiss, H. Jean Shadomy, G. Marshall Lyon III 210 $aHoboken, N.J. $cWiley-Blackwell$dc2012 215 $a1 online resource (655 p.) 300 $aDescription based upon print version of record. 311 $a0-470-17791-8 320 $aIncludes bibliographical references and index. 327 $aFundamental Medical Mycology; Fundamental Medical Mycology; Contents; Contents; Preface; Acknowledgments; Part One Introduction to Fundamental Medical Mycology, Laboratory Diagnostic Methods, and Antifungal Therapy; 1. Introduction to Fundamental Medical Mycology; 1.1 Topics not Covered, or Receiving Secondary Emphasis; 1.2 Biosafety Considerations: Before You Begin Work with Pathogenic Fungi...; 1.2.1 Biological Safety Cabinets (BSC); 1.2.2 Precautions to Take in Handling Etiologic Agents that Cause Systemic Mycoses; 1.2.3 Additional Precautions at Biosafety Level 3 (BSL 3) 327 $a1.2.4 Safety Training1.2.5 Disinfectants and Waste Disposal; 1.3 Fungi Defined: Their Ecologic Niche; 1.4 Medical Mycology; 1.5 A Brief History of Medical Mycology; 1.5.1 Ancient Greece; 1.5.2 Middle Ages; 1.5.3 Twentieth Century; 1.5.4 Endemic Mycoses in the Americas; 1.5.5 Era of Immunosuppression in the Treatment of Cancer, Maintenance of Organ Transplants, and Autoimmune Diseases; 1.5.6 Opportunistic Mycoses; 1.5.7 HIV/AIDS; 1.5.8 Twenty-first Century; 1.6 Rationale for Fungal Identification; 1.6.1 Developing the Treatment Plan; 1.6.2 Investigating Outbreaks 327 $a1.6.3 Determining the Susceptibility to Antifungal Agents1.6.4 Estimating the Significance of Fungi Generally Considered to be Opportunists or Saprobes; 1.6.5 Types of Vegetative Growth; 1.7 Sporulation; 1.8 Dimorphism; 1.8.1 Dimorphism and Pathogenesis; 1.9 Sex in Fungi; 1.9.1 Anamorph and Teleomorph Nomenclature; 1.10 Classification of Mycoses Based on the Primary Site of Pathology; 1.10.1 Superficial Mycoses; 1.10.2 Cutaneous Mycoses; 1.10.3 Systemic Opportunistic Mycoses; 1.10.4 Subcutaneous Mycoses; 1.10.5 Endemic Mycoses Caused by Dimorphic Environmental Molds 327 $a1.11 Taxonomy/Classification: Kingdom Fungi1.11.1 The Phylogenetic Species Concept for Classification; 1.11.2 The Higher Level Classification of Kingdom Fungi; 1.12 General Composition of the Fungal Cell; 1.12.1 Yeast Cell Cycle; 1.12.2 Hyphal Morphogenesis; 1.12.3 Cell Wall; 1.13 Primary Pathogens; 1.13.1 Susceptibility to Primary Pathogens; 1.14 Endemic Versus Worldwide Presence; 1.15 Opportunistic Fungal Pathogens; 1.15.1 Susceptibility to Opportunistic Fungal Pathogens: Host Factors; 1.16 Determinants of Pathogenicity; General References in Medical Mycology 327 $aSelected References for Introduction to Fundamental Medical MycologyWebsites Cited; Questions; 2. Laboratory Diagnostic Methods in Medical Mycology; 2.1 Who Is Responsible for Identifying Pathogenic Fungi?; 2.1.1 Role of the Clinical Laboratorian; 2.1.2 Role of the Physician; 2.2 What Methods are Used to Identify Pathogenic Fungi?; 2.2.1 Culture and Identification; 2.3 Laboratory Detection, Recovery, and Identification of Fungi in the Clinical Microbiology Laboratory; 2.3.1 The Laboratory Manual; 2.3.2 Specimen Collection; 2.3.3 Direct Examination; 2.3.4 Histopathology; 2.3.5 Culture 327 $a2.3.6 Storage and Cryopreservation of Cultures for QA and QC in the Clinical Mycology Laboratory 330 $aMedical mycology deals with those infections in humans, and animals resulting from pathogenic fungi. As a separate discipline, the concepts, methods, diagnosis, and treatment of fungal diseases of humans are specific. Incorporating the very latest information concerning this area of vital interest to research and clinical microbiologists,Fundamental Medical Mycology balances clinical and laboratory knowledge to provide clinical laboratory scientists, medical students, interns, residents, and fellows with in-depth coverage of each fungal disease and its etiologic agents from both the lab 606 $aMedical mycology 606 $aMicrobiology 615 0$aMedical mycology. 615 0$aMicrobiology. 676 $a616.9/6901 700 $aReiss$b Errol$0909926 701 $aShadomy$b H. Jean$0909927 701 $aLyon$b G. Marshall$0909928 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910141246603321 996 $aFundamental medical mycology$92036487 997 $aUNINA